HPE
55
11
MS
74
-2
CMCSA
48
2
PX
75
5
V
60
-6
HRL
39
15
PPL
54
2
NTAP
64
2
SIG
43
3
STI
47
-12
MA
55
-7
UNH
61
6
DG
2
-6
DNB
78
6
AKAM
43
3
IP
70
2
CSX
51
-2
DTE
50
3
DE
46
3
ROK
55
8
HPE
55
11
MS
74
-2
CMCSA
48
2
PX
75
5
V
60
-6
HRL
39
15
PPL
54
2
NTAP
64
2
SIG
43
3
STI
47
-12
MA
55
-7
UNH
61
6
DG
2
-6
DNB
78
6
AKAM
43
3
IP
70
2
CSX
51
-2
DTE
50
3
DE
46
3
ROK
55
8
Financhill
Back

InfuSystems Holdings Vs. Perspective Therapeutics Industry Stock Comparison

Buy
67

INFU
InfuSystems Holdings

Last Price:
9.22
Seasonality Move:
7.82%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.99
Seasonality Move:
34.33%
Buy
67
InfuSystems Holdings (INFU) is a Buy

Is InfuSystems Holdings a Buy, Sell or Hold?

  • The current InfuSystems Holdings [INFU] share price is $9.24. The Score for INFU is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • INFU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INFU Stock Price Chart

What is InfuSystems Holdings's stock price today?

  • The InfuSystems Holdings share price today is $9.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INFU is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

INFU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.68 Buy
Relative Strength Index (14 RSI): 69.75 Buy
Chaikin Money Flow: 41056 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.83 Sell
Relative Strength Index (14 RSI): 9.64 Sell
Chaikin Money Flow: -11653674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.08 - 12.98) Sell
Bollinger Bands (100): (10.5 - 14.68) Sell

INFU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.05 Buy
20-day SMA: 7.72 Buy
50-day SMA: 7.07 Buy
200-day SMA: 7.4 Buy
8-day EMA: 8.84 Buy
20-day EMA: 8.12 Buy
50-day EMA: 7.38 Buy
200-day EMA: 7.48 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 10.1 Sell
50-day SMA: 11.82 Sell
200-day SMA: 12.75 Sell
8-day EMA: 7.04 Sell
20-day EMA: 9.29 Sell
50-day EMA: 11.19 Sell
200-day EMA: 11.43 Sell

InfuSystems Holdings Earnings Growth & INFU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $0.07 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

InfuSystems Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):